Elan Corporation

Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.

Medikabazaar is an online B2B marketplace specializing in medical supplies and equipment, serving both medical institutions and individual practitioners. The platform simplifies procurement by allowing users to search, compare, and purchase medical products through a voice-based search engine and an online payment portal, thus reducing operational costs. With a network of over 50,000 medical establishments and 150,000 independent practitioners across India, Medikabazaar partners with more than 13,000 suppliers, including those in Tier 2 and Tier 3 cities. The company's strategic use of technology has helped organize the complex medical supply market in India, ensuring the availability of global brands at a local level. Additionally, Medikabazaar boasts a robust last-mile delivery system supported by 26 fulfillment centers nationwide, which facilitates the timely delivery of essential medical supplies and enhances the quality of patient care.

NewBridge Pharmaceuticals Ltd. is a specialty therapeutics company based in Dubai, United Arab Emirates, that focuses on pharmaceuticals, biologics, and medical diagnostics. Established in 2007, the company specializes in in-licensing and commercializing healthcare products to meet the unmet medical needs of patients in the Middle East, Africa, Turkey, and the Caspian regions. NewBridge offers a range of oncology and supportive care products, including Abstral for cancer pain management, Clasteon for bone metastasis-related conditions, Sancuso for chemotherapy-induced nausea, and Oncotype DX for breast cancer recurrence assessment. Additionally, it provides metabolic care products like Gliconorm for diabetes treatment and PYLERA for H. pylori eradication. The company's portfolio further includes CNS care products like Vimpat for seizures and Neupro for Parkinson's disease, as well as immunology care products such as Cimzia for rheumatoid arthritis. By addressing critical health issues such as cancer, diabetes, and cardiovascular diseases, NewBridge Pharmaceuticals aims to enhance patient care in its targeted regions.

Proteostasis Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cystic fibrosis and other diseases linked to protein homeostasis. The company’s primary product candidates include PTI-801, a CFTR corrector; PTI-808, a CFTR potentiator; and PTI-428, a CFTR amplifier. Proteostasis employs theratyping to tailor treatment strategies based on individual responses to CFTR modulators, regardless of specific mutations. The company collaborates with the Cystic Fibrosis Foundation and Genentech to advance its research and development efforts. Founded in 2006 and based in Boston, Massachusetts, Proteostasis was previously known as Proteoguard, Inc. and rebranded in 2007. In December 2020, it was acquired by Yumanity Therapeutics in a reverse merger transaction.

Liposome Company manufactures commercialized drug delivery systems based on liposomes.

Athena Neurosciences is focused on the research and development of therapeutic products for neurological diseases. Athena Neurosciences was founded by Larry Bock and Lawrence Fritz.